Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Surveys and Questionnaires 34 Blood Specimen Collection 24 enzalutamide 18 Radiotherapy 15 Docetaxel 15 Biopsy 14 Abiraterone Acetate 14 apalutamide 13 Leuprolide 13 Interviews as Topic 13 Observation 12 Magnetic Resonance Spectroscopy 12 Watchful Waiting 10 radium Ra 223 dichloride 9 darolutamide 9 Androgen Antagonists 9 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8 Radiosurgery 7 Magnetic Resonance Imaging 7 Brachytherapy 7 abiraterone 6 Specimen Handling 6 Amplified Fragment Length Polymorphism Analysis 6 Triptorelin Pamoate 5 Standard of Care 5 Positron Emission Tomography Computed Tomography 5 Gonadotropin-Releasing Hormone 5 Focus Groups 5 Registries 4 Radiotherapy, Intensity-Modulated 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Prostatic Neoplasms × Blood Donation × Clear all

NCT04060589 2023-03-22

ReIMAGINE Prostate Cancer Risk

University College, London

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡